We also found that KRT6B was variously expressed in patients with different histological subtypes, molecular subtypes, metastasis statuses, and individual cancer stages of BLCA through the UALCAN website [15] (Fig. 4C). The gene discussed is KRT6B; the disease is bladder transitional cell carcinoma.